Champions Oncology Inc. Common Stock (CSBR)

About CSBR

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research service…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

214

Website

championsoncology.com

Fundamentals

1-day range

$4.89$5.02

Market cap

$72.11M

P/E (trailing)

—

P/E (forward)

50.20

EPS (trailing)

$-0.08

Dividend yield

—

Beta

0.40

Avg. volume

8.7K

Champions Oncology Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• CSBR

  Champions Oncology Inc. Common Stock

  $4.93

  ▼ 1.79%
  Market cap $72.11MP/E —
  $4.83$8.74
• ELOX

  Eloxx Pharmaceuticals Inc. Common Stock

  $15.07

  ▼ 12.69%
  Market cap $71.48MP/E 5.33
  $0$23.4
• ATRA

  Atara Biotherapeutics Inc. Common Stock

  $9.16

  ▼ 0.97%
  Market cap $74.33MP/E —
  $3.92$19.15
• CGTX

  Cognition Therapeutics Inc. Common Stock

  $1.03

  ▼ 3.30%
  Market cap $79.79MP/E —
  $0.5501$3.1
• IMA

  ImageneBio Inc. Common Stock

  $5.34

  ▲ 0.19%
  Market cap $63.50MP/E —
  $3.94$13.98
• GNTA

  Genenta Science S.p.A. American Depositary Shares

  $1

  ▼ 1.96%
  Market cap $63.16MP/E —
  $0.55$10
• SCLX

  Scilex Holding Company Common Stock

  $5.42

  ▼ 2.69%
  Market cap $58.93MP/E —
  $4.2$34.27

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

5.72M

Total value held

$32.70M

Institutional holders

23